📊 Evidence-Based Reference

Silverspeed Hydrophilic Guidewire X-Celerator Hydrophilic Exchange Guidewire X-Pedion Hydrophilic Guidewire Mirage Hy

Micro Therapeutics, Inc. D/B/A: Ev3

Product: X-celeratorTM — all models and sizes

Compare similar devices

Summary: The Silverspeed Hydrophilic Guidewire is a medical device used primarily in endovascular procedures. Key evidence highlights its role in facilitating catheter advancement and its safety profile.

FDA Clearance Information

Pathway ? 510(k)
Number ? K124007 ↗
Decision Date ? March 7, 2013
Product Code ? DQX Wire, Guide, Catheter
Device Class ? Class 2
Evidence ? 419 studies

The Silverspeed Hydrophilic Guidewire was cleared by the FDA via the 510(k) pathway on March 7, 2013. It is manufactured by Micro Therapeutics, Inc. and is classified as a Class 2 device.

What It Is

The Silverspeed Hydrophilic Guidewire is designed to assist in the navigation and placement of catheters during endovascular procedures. Its hydrophilic coating reduces friction, allowing for smoother advancement through blood vessels.

FDA-Cleared Indications

  • Used to facilitate the placement and exchange of catheters during diagnostic and interventional procedures.
  • Intended for navigation through blood vessels under fluoroscopic or other imaging guidance.
  • Used with compatible catheters and accessories in adults when wire guidance is clinically indicated.

Clinical Applications

  • Guiding catheters during diagnostic angiography and other endovascular procedures.
  • Facilitating catheter advancement through tortuous or narrowed vessels.
  • Supporting catheter exchange when maintaining vascular access is necessary.
  • Assisting selective catheterization of target vessels under imaging guidance.

Reported off-label uses

  • Guidewire support during selected nonvascular catheter procedures, such as endoscopic retrograde cholangiopancreatography, when the specific product labeling and institutional policies permit it.
  • Use in selected embolization procedures, including uterine artery embolization, as part of catheter navigation; the exact indication depends on the individual product labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes a mix of RCTs, prospective, and retrospective studies, with a total of 10 studies reviewed. The studies span from 2022 to 2023, focusing on various clinical applications of hydrophilic guidewires.

Reported Outcomes

Published studies report that the Silverspeed Hydrophilic Guidewire effectively facilitates catheter advancement in endovascular procedures. It has been shown to improve procedural success rates in neurovascular and gynecological interventions.

Safety Profile

Reported complications include fragmentation of the hydrophilic coating, which may lead to embolism. However, the overall safety profile is considered acceptable when used as intended.

Evidence Limitations

Current evidence is limited by the small size of some studies and the lack of long-term follow-up data. Further research is needed to fully understand the mechanisms of coating fragmentation and its clinical implications.

Practical Considerations

  • Available dimensions, tip shapes, stiffness, and radiopaque-marker configurations vary by model; choose a wire compatible with the catheter, access sheath, and target anatomy.
  • The hydrophilic coating should be activated and maintained according to the instructions for use. Avoid advancing or withdrawing the wire against significant resistance.
  • Use fluoroscopy or other appropriate imaging to monitor the wire tip and reduce the risk of vessel injury, perforation, dissection, or entanglement.
  • MRI safety is model-specific. Confirm the exact guidewire's current labeling before MRI; do not assume that all hydrophilic guidewires are MR safe or MR conditional.
  • Potential complications include bleeding, thrombosis, embolization, vasospasm, vessel dissection, perforation, infection, and device fracture or retention.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Silverspeed Hydrophilic Guidewire?

The guidewire is indicated for use in endovascular procedures such as neuroendovascular therapy and uterine artery embolization.

What outcomes have been reported in clinical studies?

Studies report improved catheter advancement and procedural success rates in various interventions.

What complications have been reported?

Safety data indicates potential complications such as coating fragmentation leading to embolism.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you